National Genetics Institute begins viral screening trial
This article was originally published in Clinica
Executive Summary
National Genetics Institute (NGI) has begun clinical trials of its robotic acid amplification technique. It will screen donated plasma for HIV-1, HIV-2 and hepatitis C virus (HCV) using the Roche Molecular Systems polymerase chain reaction (PCR) method.